Cargando…
PGE2 and Poloxamer Synperonic F108 Enhance Transduction of Human HSPCs with a β-Globin Lentiviral Vector
Lentiviral vector (LV)-based hematopoietic stem and progenitor cell (HSPC) gene therapy is becoming a promising alternative to allogeneic stem cell transplantation for curing genetic diseases. Clinical trials are currently underway to treat sickle cell disease using LVs expressing designed anti-sick...
Autores principales: | Masiuk, Katelyn E., Zhang, Ruixue, Osborne, Kyle, Hollis, Roger P., Campo-Fernandez, Beatriz, Kohn, Donald B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477655/ https://www.ncbi.nlm.nih.gov/pubmed/31024981 http://dx.doi.org/10.1016/j.omtm.2019.03.005 |
Ejemplares similares
-
Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes
por: Piovan, Claudia, et al.
Publicado: (2017) -
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
por: Poletti, Valentina, et al.
Publicado: (2018) -
β-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion Production
por: Han, Jiaying, et al.
Publicado: (2020) -
The human ankyrin 1 promoter insulator sustains gene expression in a β-globin lentiviral vector in hematopoietic stem cells
por: Romero, Zulema, et al.
Publicado: (2015) -
Development of Antifouling Polysulfone Membranes by Synergistic Modification with Two Different Additives in Casting Solution and Coagulation Bath: Synperonic F108 and Polyacrylic Acid
por: Burts, Katsiaryna S., et al.
Publicado: (2022)